The two Pharma experts will be acting as advocates in strategic topics and support the Group vision and growth.
Stevanato Group will be able to offer extended analytical and extractables & leachables testing services to determine the drug integrity during its entire life cycle.
Ompi, the company within Stevanato Group specialized in glass primary packaging for the pharmaceutical industry, has signed a license agreement with Gerresheimer. The agreement reaffirms Ompi EZ-fill solution as the worldwide proven standard in processing sterile glass vials and cartridges.
One year after the groundbreaking ceremony of Ompi production plant in Brazil, held on February 4th 2016, Avenida Giovanni Stevanato has been inaugurated today. The avenue leading to the Ompi plant, part of the Italian Stevanato Group, is named in memory of the founder Group. The inauguration was held with the participation of the Mayor of Sete Lagoas, local authorities and company’s top executives.
Ompi presents at Pharmapack Paris its integrated needlestick protection to prevent end users’ injury
Ompi expands its Ompi EZ-fill® Syringes offer by adding up an Integrated Safety System (ISS) for staked needle syringes. Ompi EZ-fill® ISS is a brand new fully passive safety system designed to guarantee end users’ safety and reduce total cost of ownership for the pharmaceutical companies.
Stevanato Group, leader in glass containers manufacturing for pharmaceutical use, wins the Mercurio Award 2016 for the significant Italian-German economic cooperation and the acquisition in 2016 of the operational activities of Balda AG.
Stevanato Group, specializing in glass pharmaceutical primary packaging, glass converting machines, visual inspection systems, assembling and packaging machines for the pharmaceutical industry, announces the acquisition of the operating units of the German Balda Group.
The Group, specializing in glass pharmaceutical primary packaging, glass converting machines and visual inspection systems for the pharmaceutical industry, registered revenues for 337,1 million Euros in 2015, with an increase of 16,8% from 2014 and 87,1 million Euros EBITDA (25,8% on revenues).
Stevanato Group, international leader in cartridges production for diabetes treatment, glass containers for pharmaceutical use, glass tube converting machines and visual inspection systems for the pharmaceutical industry, strengthens its Engineering Systems division by acquiring the 65% of the Danish SVM Automatik, a company specialized in assembly, packaging machines and serialization solutions headquartered in Silkeborg, Denmark.
The Group, leader in manufacturing cartridges for insulin and glass primary packaging for the pharmaceutical industry as well as in the production of complete forming and converting machines for glass products, continues its double digit growth.
Stevanato Group registered revenue for 237,4 million Euro at the end of the third quarter 2015, with a 17,4% increase from the same period of 2014, with relevant increases in both divisions: Pharmaceutical Systems and Engineering Systems.